Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Background Liver cirrhosis is an uncommon but not rare side effect of amiodarone-induced
hepatotoxicity. Patients with hepatitis B virus and hepatitis C virus infections are at a high …

Background and Aims: Drug-induced liver injury (DILI) is the main cause of drug withdrawal
from the market. It is an adverse reaction that even when it was not observed in clinical trials …

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …

What is known and objective We present a case of intravenous amiodarone‐induced liver
injury, pharmacy monitoring and its therapy. Case Summary A 76‐year‐old male patient …

Introduction Drug-induced liver injury (DILI) is the most frequent cause of acute liver failure
in North America and Europe, but it is often missed because of unstandardized diagnostic …

Hepatotoxicity caused by chronic oral amiodarone is well documented with around 15-20%
incidence rate. However, acute liver failure due to intravenous (IV) amiodarone is rare …

What is known and objective Amiodarone, a commonly used class III antiarrhythmic agent
notable for a relatively long half‐life of up to 6 months and its pronounced adverse effect …

The current study aimed to identify the crude drugs associated with drug-induced liver injury
(DILI) in 148 Kampo medicines prescribed throughout Japan using the Japanese Adverse …

Abstract Objective Adverse drug reactions (ADRs) can involve all tissues and organs. Liver
injuries are considered among the most serious and are a cause for concern among …